• Explore /
  • Poster
  • / Phase I/II study of <sup>225</sup>Ac-J591 plus <sup>177</sup>Lu-PSMA-I&T for progressive metastatic castration-resistant prostate cancer.

Phase I/II study of 225Ac-J591 plus 177Lu-PSMA-I&T for progressive metastatic castration-resistant prostate cancer.

Abstract Poster

Authors

null

Jones T. Nauseef

New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY

Jones T. Nauseef , Joseph Osborne , Peter Gregos , Charlene Thomas , Mahelia Bissassar , Sharon Singh , Amie Patel , Angela Tan , Muhammad Obaid Naiz , Juana Martinez Zuloaga , Tessa Chamberlain , Kara Earle , Rebecca Wunder , Himanshu Nagar , Ana M. Molina , Cora N. Sternberg , David M. Nanus , Neil Harrison Bander , Scott T. Tagawa

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Castrate-Resistant

Clinical Trial Registration Number

04886986

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr TPS5100)

DOI

10.1200/JCO.2022.40.16_suppl.TPS5100

Abstract #

TPS5100

Poster Bd #

279b

Abstract Disclosures

Similar Posters

First Author: Michael Sun

First Author: Kim N. Chi

First Author: Scott T. Tagawa

First Author: Mark Christopher Markowski